Back to search

National and Kapodistrian University of Athens

Συμβολή στην κλινική εκτίμηση αντιμετώπιση και παθολογοανατομική μελέτη των κακοήθων όγκων των σιελογόνων αδένων

Abstract

dc:description

Salivary gland cancer is rare, with incidence of one new case per 100,000 people per year, representing 3-6% of head and neck cancer. Additionally, occurs great histopathological heterogeneity, with 23 different histological types according to current classification. These two characteristics make collection and analysis of data required for guidelines development and prognosis determination more complex compared to other cancer types. In T1 and T2 tumors, with clinically N0 neck, even if there is evidence of free margins, guidelines require existence of prognostic factors in order radiation need to be determined. Another case of not strict guidelines are low grade T1 and T2 tumors. These examples highlight the need of salivary glands cancer prognostic factors seek and identification, apart from the already known (stage, nodal involvement, degree of differentiation). Role of immunochemistry is essential in the cancer patient’s management during the last years. The ability to indicate antigens in specific types of cancer cells, allowed the development of antigens able to target specific antigens, fact that opened new horizons in cancer treatment. A series of studies have been dedicated to detection of immunochemistry agents and their potential role in tumorigenesis and prognosis of salivary glands cancer. Aim of the present study was to investigate the role of four factors: onco-protein p53, proliferation marker Κi-67, intermediate filament e-cadherin and GFAP (Glial fibrillary acidic protein). Regarding to these factors, there was previous literature connecting them to other cancer types, but lack of sufficient or even total absence of studies about their role in salivary gland cancer. Thirty three patients with salivary gland cancer were included in the study, 15 males and 18 females. The four factors were detected and epidemiological and clinical data were recorded as well (stage, histological type, nodal involvement, therapy). The follow up time ranged between one and ten years, with a mean of 3.32 years. In 27.3 of these patients suffered from recurrence and 18.2% died because of the disease. Ki-67 was found 36,3%, p53 in 33%, e-cadherin in 72% and GFAP in 50% of the patients. Statistical analysis of the results both with correlation and survival method revealed a statistically significant relationship between Ki-67 and p53 expression with recurrence rate and disease-related survival. For the other two factors, no such relationship was found. E-cadherin, in contrary, correlated with increased survival possibilities.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Mireas, Georgios
  • Μοιρέας, Γεώργιος

Subjects

dc:subject × 19

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/41312

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Mireas, Georgios; Μοιρέας, Γεώργιος. Συμβολή στην κλινική εκτίμηση αντιμετώπιση και παθολογοανατομική μελέτη των κακοήθων όγκων των σιελογόνων αδένων. National and Kapodistrian University of Athens, 2013. http://hdl.handle.net/10442/hedi/41312